Guadalupe Galindo
Family · Bakersfield, CANPI 1417352691
Payments from drug & device makers
Across 101 payments — averaging $23.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$429
- Novo Nordisk$381
- Abbott$218
- Corcept Therapeutics$204
- AstraZeneca$198
- Lilly USA, LLC$192
- plus $702 from 18 others
What the payments were for
- Food & beverage$2,316100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 8 | $429 |
| Novo Nordisk | 23 | $381 |
| Abbott | 15 | $218 |
| Corcept Therapeutics | 6 | $204 |
| AstraZeneca | 7 | $198 |
| Lilly USA, LLC | 10 | $192 |
| Mannkind Corporation | 6 | $134 |
| Dexcom, Inc. | 5 | $99 |
| Phadia US Inc. | 3 | $68 |
| Tandem Diabetes Care, Inc. | 1 | $64 |
| Novartis | 3 | $62 |
| Ascensia Diabetes Care US Inc. | 2 | $38 |
| Ascendis Pharma Endocrinology Inc | 1 | $31 |
| Boehringer Ingelheim | 1 | $31 |
| Averitas Pharma Inc. | 1 | $23 |
| Bayer | 1 | $23 |
| Amryt Pharma Holdings Ltd | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Merck | 1 | $17 |
| GSK | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $15 |
| Cequr Corporation | 1 | $14 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$157
- Korlym$110
How this compares
$2,324 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 88 | $83,968 |
| TrulicityDulaglutide | 56 | $63,470 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 41 | $33,490 |
| FarxigaDapagliflozin Propanediol | 38 | $30,929 |
| Xigduo XrDapaglifloz Propaned/Metformin | 32 | $22,352 |
| JardianceEmpagliflozin | 29 | $22,105 |
| Tresiba Flextouch U-200Insulin Degludec | 33 | $18,910 |
| JanuviaSitagliptin Phosphate | 20 | $16,282 |
| RybelsusSemaglutide | 11 | $12,062 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $9,291 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 30 | $8,825 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 17 | $7,198 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 70 | $5,634 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 47 | $3,789 |
| Novolog FlexpenInsulin Aspart | 21 | $2,396 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $381 | $96,03199 claims |
| Lilly USA, LLCTrulicity | $192 | $63,47056 claims |
| Boehringer IngelheimSynjardy Xr, Jardiance | $31 | $55,59570 claims |
| AstraZenecaFarxiga | $198 | $30,92938 claims |
| MerckJanuvia | $17 | $16,28220 claims |
| Sanofi-aventis U.S. LLCLantus | $18 | $1,61316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.
Other family in Bakersfield
- Jennifer TougasBakersfield$302K
- Ashton ChaseBakersfield$86K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.